###begin article-title 0
###xml 89 90 89 90 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fn" rid="fn1">*</xref>
###xml 90 92 90 92 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fn" rid="fn2">s&#8414;</xref>
###xml 42 46 <span type="species:ncbi:10090">mice</span>
Inactivation of hypothalamic FAS protects mice from diet-induced obesity and inflammation*sâƒž
###end article-title 0
###begin p 1
###xml 52 70 52 70 <email xmlns:xlink="http://www.w3.org/1999/xlink">csemenko@wustl.edu</email>
To whom correspondence should be addressed. e-mail: csemenko@wustl.edu
###end p 1
###begin p 2
###xml 0 15 0 15 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Author's Choice</bold>
###xml 0 44 0 44 <italic xmlns:xlink="http://www.w3.org/1999/xlink"><bold>Author's Choice</bold> - Final version full access.</italic>
Author's Choice - Final version full access.
###end p 2
###begin p 3
 applies to Author Choice Articles
###end p 3
###begin p 4
###xml 411 415 <span type="species:ncbi:10090">mice</span>
###xml 571 575 <span type="species:ncbi:10090">mice</span>
###xml 895 899 <span type="species:ncbi:10090">mice</span>
###xml 920 924 <span type="species:ncbi:10090">mice</span>
Obesity promotes insulin resistance and chronic inflammation. Disrupting any of several distinct steps in lipid synthesis decreases adiposity, but it is unclear if this approach coordinately corrects the environment that propagates metabolic disease. We tested the hypothesis that inactivation of FAS in the hypothalamus prevents diet-induced obesity and systemic inflammation. Ten weeks of high-fat feeding to mice with inactivation of FAS (FASKO) limited to the hypothalamus and pancreatic beta cells protected them from diet-induced obesity. Though high-fat fed FASKO mice had no beta-cell phenotype, they were hypophagic and hypermetabolic, and they had increased insulin sensitivity at the liver but not the periphery as demonstrated by hyperinsulinemic-euglycemic clamps, and biochemically by increased phosphorylated Akt, glycogen synthase kinase-3beta, and FOXO1 compared with wild-type mice. High-fat fed FASKO mice had decreased excretion of urinary isoprostanes, suggesting less oxidative stress and blunted tumor necrosis factor alpha (TNFalpha) and interleukin-6 (IL-6) responses to endotoxin, suggesting less systemic inflammation. Pair-feeding studies demonstrated that these beneficial effects were dependent on central FAS disruption and not merely a consequence of decreased adiposity. Thus, inducing central FAS deficiency may be a valuable integrative strategy for treating several components of the metabolic syndrome, in part by correcting hepatic insulin resistance and suppressing inflammation.
###end p 4
###begin p 5
Published, JLR Papers in Press, November 22, 2008.
###end p 5
###begin p 6
###xml 281 282 281 282 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib1">1</xref>
###xml 353 354 353 354 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib2">2</xref>
###xml 432 433 432 433 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib3">3</xref>
###xml 542 543 542 543 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib4">4</xref>
###xml 632 633 632 633 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib5">5</xref>
Constant availability of food and sedentary living in contemporary wealthy cultures has dramatically limited the ability to utilize fat stores, resulting in an obesity epidemic. Worldwide, at least 1 in 10 adults is obese, and more than 25% are affected in many Western countries (1), leading to striking increases in type 2 diabetes and heart disease (2). Over a quarter of adults in the United States have the metabolic syndrome (3), a combination of central obesity, glucose intolerance/insulin resistance, dyslipidemia, and hypertension (4), that confers a 2- to 3-fold increase risk for cardiovascular morbidity and mortality (5).
###end p 6
###begin p 7
###xml 637 638 626 627 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib6">6</xref>
###xml 638 638 627 627 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib7"/>
###xml 638 638 627 627 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib8"/>
###xml 638 638 627 627 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib9"/>
###xml 638 638 627 627 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib10"/>
###xml 638 638 627 627 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib11"/>
###xml 638 638 627 627 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib12"/>
###xml 638 638 627 627 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib13"/>
###xml 639 641 628 630 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib14">14</xref>
###xml 911 913 900 902 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib15">15</xref>
###xml 1023 1025 1012 1014 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib16">16</xref>
###xml 119 123 <span type="species:ncbi:10090">mice</span>
###xml 195 199 <span type="species:ncbi:10090">Mice</span>
###xml 798 802 <span type="species:ncbi:10090">mice</span>
###xml 947 951 <span type="species:ncbi:10090">mice</span>
Given the reluctance of most modern adults to eat less and exercise more, many groups have altered lipid metabolism in mice in hopes of establishing proof of principle for new obesity therapies. Mice are resistant to diet-induced obesity after genetic manipulations that decrease lipid synthesis (acetyl-CoA carboxylase-2, stearoyl-CoA desaturase-1, diacylglycerol acyltransferase-1) and adipogenesis [peroxisome-proliferator-activated receptor (Ppar)gamma], increase mitochondrial gene expression (Ppardelta), increase respiratory uncoupling (uncoupling protein-1, liver X receptor), or perturb intracellular signaling (Ikkbeta, S6k1) (6-14). However, it is not clear that simply decreasing adiposity will universally improve the metabolic disease milieu. For instance, liver X receptor-deficient mice have increased metabolism, yet they are predisposed to the chronic inflammatory process of atherosclerosis (15). Stearoyl-CoA desaturase-1 null mice are also hypermetabolic and thin but are predisposed to acute colitis (16).
###end p 7
###begin p 8
###xml 128 130 128 130 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib17">17</xref>
###xml 230 232 230 232 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib18">18</xref>
###xml 444 446 444 446 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib19">19</xref>
We recently identified hypothalamic expression of another key protein in lipid metabolism, as a mediator of energy homeostasis (17). FAS is ubiquitously expressed and catalyzes the first committed step in fatty acid biosynthesis (18). Pharmacologic inhibition of this enzyme with compounds such as C75 had previously implicated FAS in bioenergetics, but the lack of specificity of C75, notably its activation of the sympathetic nervous system (19), raised the possibility that mechanisms independent of FAS could be involved.
###end p 8
###begin p 9
###xml 27 29 27 29 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib20">20</xref>
###xml 464 466 455 457 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib17">17</xref>
###xml 21 25 <span type="species:ncbi:10090">mice</span>
###xml 387 391 <span type="species:ncbi:10090">mice</span>
###xml 737 742 <span type="species:ncbi:9606">human</span>
###xml 918 922 <span type="species:ncbi:10090">mice</span>
By mating FAS floxed mice (20) with RIPCre transgenic animals (known to express the Cre recombinase in pancreatic beta cells and the hypothalamus), we generated animals with FAS deficiency limited to pancreatic beta cells and the hypothalamus (FASKO). The lack of FAS, at least on a standard chow diet, did not affect beta-cell function. However, hypothalamic FAS deficiency resulted in mice that were hypophagic, hypermetabolic, and lean on a standard chow diet (17). While these results provided unexpected insights into the role of hypothalamic FAS in feeding and behavior, they did not address effects of this manipulation on the risk for diet-induced obesity, insulin resistance, and chronic inflammation that are characteristic of human type 2 diabetes and metabolic syndrome. In addition, the high-fat feeding paradigm also allowed us to critically examine whether the beneficial metabolic effects in the FASKO mice are simply a consequence of decreased adiposity or due to a specific perturbation in central FAS signaling. Here we report the results of experiments testing the hypothesis that deficiency of hypothalamic FAS prevents diet-induced obesity and systemic inflammation, clinically relevant endpoints.
###end p 9
###begin title 10
MATERIALS AND METHODS
###end title 10
###begin title 11
Animals and feeding studies
###end title 11
###begin p 12
###xml 284 286 281 283 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib17">17</xref>
###xml 684 688 681 685 <sup xmlns:xlink="http://www.w3.org/1999/xlink">0.75</sup>
###xml 775 777 772 774 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib21">21</xref>
###xml 93 97 <span type="species:ncbi:10090">mice</span>
###xml 1029 1033 <span type="species:ncbi:10090">mice</span>
###xml 1101 1105 <span type="species:ncbi:10090">mice</span>
###xml 1169 1173 <span type="species:ncbi:10090">mice</span>
###xml 1264 1268 <span type="species:ncbi:10090">mice</span>
Protocols were approved by the Washington University Animal Studies Committee. Generation of mice with FAS deletion in the hypothalamus and pancreatic beta cells (FASKO), and wild-type (Cre negative with the FAS floxed allele) in a mixed (BL/6 and 129) background has been described (17). Starting at 6 weeks of age, FASKO and wild-type littermates were started on a Western-style diet (TD 88137, Harlan Teklad) [high-fat diet (HFD)] containing 21% (w/w) total lipid and 0.15% (w/w) total cholesterol for 10 weeks. Fatty acid composition of this diet is presented in supplementary Table I. Body weight was recorded weekly, and food intake [expressed as a function of lean body mass (g0.75)] was measured biweekly. On week 8, stools were collected to determine lipid content (21), and percentage of consumed lipid that was absorbed was calculated as (food intake x food lipid content) - (stool output x stool lipid content)/(food intake x food lipid content) x 100. After 10 weeks of high-fat feeding, another cohort of wild-type mice received an amount of food identical to that consumed by the FASKO mice (pair-fed) for an additional 15 days. These pair-fed wild-type mice were then subjected to the same experiments (see below) as freely fed wild-type and FASKO mice.
###end p 12
###begin title 13
Analytical procedures
###end title 13
###begin p 14
###xml 248 250 245 247 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib17">17</xref>
###xml 252 254 249 251 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib20">20</xref>
###xml 388 390 385 387 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib20">20</xref>
###xml 468 470 465 467 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib21">21</xref>
Body composition, indirect calorimetry, locomotor activity, serum glucose, insulin, nonesterified fatty acids, triglycerides, cholesterol, beta-hydroxybutyrate, leptin, adiponectin, glucose, and insulin tolerance tests were performed as described (17, 20). Hepatic lipids were extracted in chloroform/methanol (2:1, v/v) followed by determination of triglyceride and cholesterol content (20). Serum lipoprotein profiles were analyzed by size exclusion chromatography (21).
###end p 14
###begin title 15
Islet isolation and insulin secretion
###end title 15
###begin p 16
###xml 53 55 53 55 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib22">22</xref>
###xml 168 170 168 170 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib22">22</xref>
###xml 264 266 264 266 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib17">17</xref>
Pancreatic islets isolated by collagenase digestion (22) were cultured with 3 mM and 16.7 mM glucose, or 10 mM arginine, and insulin secreted in the media was assayed (22). Insulin content of islets and whole pancreas was determined after acid-ethanol extraction (17).
###end p 16
###begin title 17
Immunohistochemistry and morphometry
###end title 17
###begin p 18
###xml 55 57 55 57 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib20">20</xref>
###xml 169 171 169 171 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib23">23</xref>
###xml 246 248 246 248 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib20">20</xref>
###xml 405 407 399 401 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib17">17</xref>
Adipose and liver tissues were processed as described (20). Adipose sections were stained with anti-F4/80 antibody (1:200, Abcam) and visualized using NovoRed (Vector) (23). Livers were stained with Oil Red O (Sigma) to visualize neutral lipids (20). Immunohistochemical and morphometric analyses for islet area, beta cell, and non-beta cell mass by point-counting morphometry utilized described methods (17).
###end p 18
###begin title 19
Hyperinsulinemic-euglycemic clamps
###end title 19
###begin p 20
###xml 40 42 40 42 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib24">24</xref>
###xml 125 126 125 126 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3</sup>
###xml 560 561 558 559 <italic xmlns:xlink="http://www.w3.org/1999/xlink">a</italic>
###xml 560 561 558 559 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>a</italic></sub>
###xml 615 616 613 614 <italic xmlns:xlink="http://www.w3.org/1999/xlink">d</italic>
###xml 615 616 613 614 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>d</italic></sub>
###xml 648 650 646 648 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib24">24</xref>
###xml 80 84 <span type="species:ncbi:10090">mice</span>
###xml 209 214 <span type="species:ncbi:9606">Human</span>
Internal jugular catheters were placed (24), and after a 3-day recovery period, mice were subjected to an overnight fast. 3-[3H]glucose (PerkinElmer) was first infused (0.05 muCi/min) for 2 h to steady state. Human regular insulin was then bolused (50 muU/g) followed by a constant infusion at either 5 mU/kg/min (low-dose clamp) or 20 mU/kg/min (high-dose clamp) in separate cohorts of HFD fed animals. Infusion of 20% D-glucose was varied to maintain blood glucose at basal concentrations for at least 90 min. Rates of basal and clamped glucose production (Ra), and insulin-stimulated whole body glucose uptake (Rd) were determined as described (24).
###end p 20
###begin title 21
Analysis of insulin signaling and immunoblotting
###end title 21
###begin p 22
###xml 269 271 269 271 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib20">20</xref>
###xml 413 416 412 415 <sup xmlns:xlink="http://www.w3.org/1999/xlink">473</sup>
###xml 468 469 467 468 <sup xmlns:xlink="http://www.w3.org/1999/xlink">9</sup>
###xml 549 552 548 551 <sup xmlns:xlink="http://www.w3.org/1999/xlink">256</sup>
###xml 741 743 740 742 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib20">20</xref>
###xml 132 136 <span type="species:ncbi:10090">mice</span>
Acute insulin stimulation was performed by intraportal injections (0.1 or 10 U/kg body weight) of regular insulin into anesthetized mice. Ten min later, liver and gastrocnemius were clamp-frozen and homogenized in buffer containing protease and phosphatase inhibitors (20). Thirty mug of total protein was resolved by SDS-PAGE, electrotransferred onto PVDF membranes (Millipore), and immunoblotted with total and 473Ser-phosphoAkt (1:1,000, cell signaling), total and 9Ser-phospho glycogen synthase kinase-3beta (1:1.000, cell signaling), total and 256Ser-phosphoFOXO1 (1:1,000, cell signaling), TRB3 (1:2,500, Calbiochem), and actin (1:5,000, Sigma). Total and phospho-specific bands were detected by chemiluminescence (ECL kit, Amersham) (20).
###end p 22
###begin title 23
Quantitative RT-PCR
###end title 23
###begin p 24
###xml 138 140 138 140 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib17">17</xref>
###xml 142 144 142 144 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib20">20</xref>
###xml 207 208 207 208 <sub xmlns:xlink="http://www.w3.org/1999/xlink">T</sub>
RNA isolation, reverse transcription, and PCR (Applied BioSystems 7700) were performed using previously published primer-probe sequences (17, 20). Relative mRNA levels were calculated using the comparative CT and standard curve methods normalized to ribosomal protein L32, an invariant internal control.
###end p 24
###begin title 25
Oxidative stress and inflammatory stimuli
###end title 25
###begin p 26
###xml 119 121 119 121 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2t</sub>
###xml 318 322 <span type="species:ncbi:10090">mice</span>
Urine was collected for 24 h in the presence of the antioxidant butylated hydroxytoluene (0.005%), and 15-isoprostane F2t and creatinine were analyzed by enzyme-linked immunosorbent assay (Oxford Biochemicals) and colorimetric assay (Cayman Chemical), respectively. In a separate cohort of HFD fed wild-type and FASKO mice, lipopolysaccharide (7 mg/kg, serotype 0111:B4, Sigma) was injected intraperitoneally, and serum was obtained before injection and at 1, 3, and 6 h after injection. Tumor necrosis factor alpha (TNFalpha) and interleukin-6 (IL-6) were measured in serum by enzyme-linked immunosorbent assay (BD Biosciences).
###end p 26
###begin title 27
Statistical analyses
###end title 27
###begin p 28
###xml 115 116 113 114 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t</italic>
###xml 186 187 184 185 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
Data are expressed as mean +/- SEM. Statistical comparisons were performed using an unpaired, two-tailed Student's t-test or ANOVA (ANOVA). If the overall F was found to be significant (P < 0.05) for the latter, comparisons between means were made using appropriate posthoc tests.
###end p 28
###begin title 29
RESULTS
###end title 29
###begin title 30
###xml 6 10 <span type="species:ncbi:10090">mice</span>
FASKO mice resist HFD-induced weight gain and are hypermetabolic
###end title 30
###begin p 31
###xml 124 131 124 131 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Fig. 1A</bold>
###xml 124 131 124 131 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig"><bold>Fig. 1A</bold></xref>
###xml 131 133 131 133 <bold xmlns:xlink="http://www.w3.org/1999/xlink">, </bold>
###xml 133 134 133 134 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 133 134 133 134 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig"><bold>B</bold></xref>
###xml 186 193 186 193 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1A</xref>
###xml 195 196 195 196 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">B</xref>
###xml 311 318 287 294 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1C</xref>
###xml 10 14 <span type="species:ncbi:10090">mice</span>
###xml 180 184 <span type="species:ncbi:10090">mice</span>
###xml 205 209 <span type="species:ncbi:10090">mice</span>
Wild-type mice gained weight (35% and 23% increase from baseline in males and females, respectively) after 10 weeks of HFD (Fig. 1A, B). Weight gain was considerably less in FASKO mice (Fig. 1A, B). FASKO mice after HFD feeding had approximately30% lower adiposity and an approximately8% increase in lean mass (Fig. 1C). There was no genotype effect on nasoanal lengths (not shown).
###end p 31
###begin p 32
###xml 836 837 832 833 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 37 41 <span type="species:ncbi:10090">mice</span>
###xml 264 268 <span type="species:ncbi:10090">mice</span>
###xml 298 302 <span type="species:ncbi:10090">mice</span>
###xml 673 678 <span type="species:ncbi:10090">mouse</span>
Fatty acid synthase knockout (FASKO) mice resist high-fat diet (HFD)-induced weight gain. A, B: Total body weight (top panels) and body weight gained (bottom panels) during 10 weeks of high-fat feeding in male (n = 18) and female (n = 12) wild-type (WT) and FASKO mice. C: Body composition of male mice by dual energy X-ray absorptiometry after 10 weeks of HFD. Fat (top panel) and lean (bottom panel) mass are represented as percentage of total body mass. D: Representative hematoxylin and eosin-stained sections of perigonadal white adipose tissue (x20 magnification) after 10 weeks of HFD (top panel). Distribution curve of diameters (bottom panel) of 350 fat cells per mouse shows an equal preponderance of small (20-40 mum) and large (40-60 mum) adipocytes in both genotypes (n = 5 per group). All graphs represent mean +/- SEM. * P < 0.05 compared with WT littermates.
###end p 32
###begin p 33
###xml 225 226 221 222 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 327 328 323 324 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 381 388 377 384 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1D</xref>
Decreased adiposity in HFD fed FASKO animals was reflected by changes in white adipose tissue but not brown adipose tissue mass. Perigonadal fat pads weighed 3.17 +/- 0.58 g in FASKO vs. 6.15 +/- 1.12 g in wild-type, N = 10, P = 0.03). Intrascapular brown adipose tissue depots weighed 0.35 g in FASKO vs. 0.36 g in wild-type, P = NS. Adipocyte size was similar between genotypes (Fig. 1D).
###end p 33
###begin p 34
###xml 94 101 94 101 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Fig. 2A</bold>
###xml 94 101 94 101 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig"><bold>Fig. 2A</bold></xref>
###xml 170 177 170 177 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2B</xref>
###xml 230 231 230 231 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 327 334 327 334 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2C</xref>
###xml 550 557 550 557 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2D</xref>
###xml 693 694 685 686 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 719 726 711 718 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2E</xref>
###xml 747 754 739 746 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2F</xref>
###xml 1012 1019 1000 1007 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2G</xref>
###xml 1344 1351 1332 1339 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2H</xref>
###xml 6 10 <span type="species:ncbi:10090">mice</span>
###xml 456 460 <span type="species:ncbi:10090">mice</span>
###xml 1182 1186 <span type="species:ncbi:10090">mice</span>
FASKO mice ate 17-22% less than controls at baseline and at 4, 7, and 10 weeks of eating HFD (Fig. 2A), exhibiting normal fat absorption at the end of the dietary study (Fig. 2B). FASKO animals demonstrated a 14-19% increase in VO2 compared with their wild-type littermates at baseline and at 4, 7, and 10 weeks of eating HFD (Fig. 2C). The respiratory quotient was similar between genotypes at the end of the dietary study, suggesting that although FASKO mice had increased oxygen consumption, their substrate utilization was the same as wild-type (Fig. 2D). There were no genotype-specific differences in serum beta-hydroxybutyrate (FASKO 193 +/- 26 vs. wild-type 215 +/- 57 mumol/L, N = 7, P = NS), heat production (Fig. 2E), body temperature (Fig. 2F), or in the expression of genes controlling fat oxidation in liver (Pparalpha, acyl-CoA oxidase, carnitine palmitoyl transferase-1, medium-chain acyl-CoA dehydrogenase), skeletal muscle (lipoprotein lipase), and brown adipose tissue (uncoupling protein-1) (Fig. 2G), all of which suggested that elevated metabolism in peripheral tissues is unlikely to contribute to the increased whole-body energy expenditure in HFD fed FASKO mice. In contrast, HFD fed FASKO animals had increased locomotor activity assessed using an infrared sensing technique to measure home-cage activity over 3 days (Fig. 2H). Together, these data suggest that enhanced oxygen consumption in FASKO animals on a HFD appears to be mostly due to increased physical activity, which in combination with hypophagia protects them from diet-induced obesity.
###end p 34
###begin p 35
###xml 292 293 292 293 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 1095 1096 1093 1094 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 83 87 <span type="species:ncbi:10090">mice</span>
###xml 927 931 <span type="species:ncbi:10090">mice</span>
Energy balance in response to HFD. A: Ad libitum daily food intake in WT and FASKO mice at the indicated times of the dietary study (n = 7-10). BW, body weight. B: Fat absorption, analyzed as described in Materials and Methods, at the end of 10 weeks of HFD (n = 7). C: Oxygen consumption (VO2) by indirect calorimetry integrated over a 24-h period at the indicated times of the dietary study (n = 12-15). D, E: Respiratory exchange ratio (D) and heat generation (E) by indirect calorimetry integrated over a 24-h period after 10 weeks of HFD (n = 12-15). F: Body temperature after 10 weeks of HFD (n = 11). G: Expression of the indicated genes involved in fatty acid oxidation was measured after 10 weeks of HFD in the liver, gastrocnemius (Sk.M), and brown adipose tissue by RT-PCR and normalized to L32 ribosomal mRNA levels in the same sample. Data represent three independent RT-PCR experiments for each gene with n = 4-5 mice per genotype. H: Locomotor activity after 10 weeks of HFD was quantified using infrared sensors over a 3-day period (n = 18). All graphs represent mean +/- SEM. * P < 0.05 compared with WT littermates.
###end p 35
###begin title 36
###xml 55 59 <span type="species:ncbi:10090">mice</span>
Effect of HFD on serum and tissue metabolites in FASKO mice
###end title 36
###begin p 37
###xml 94 100 94 100 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Fig. 3</bold>
###xml 94 100 94 100 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig"><bold>Fig. 3</bold></xref>
###xml 142 144 142 144 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib17">17</xref>
###xml 284 291 284 291 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3A</xref>
###xml 293 294 293 294 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">B</xref>
###xml 331 338 331 338 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3C</xref>
###xml 679 686 679 686 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3D</xref>
###xml 1056 1063 1044 1051 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3E</xref>
###xml 1139 1146 1127 1134 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3F</xref>
###xml 278 282 <span type="species:ncbi:10090">mice</span>
###xml 506 510 <span type="species:ncbi:10090">mice</span>
###xml 900 904 <span type="species:ncbi:10090">mice</span>
###xml 1072 1076 <span type="species:ncbi:10090">mice</span>
Serum chemistries and adipokines were unaffected by genotype at baseline (week 0, chow diet) (Fig. 3), consistent with our previous findings (17). High-fat feeding increased fasting glucose and insulin in both genotypes, but levels of both were lower at 7 and 10 weeks in FASKO mice (Fig. 3A, B). Nonesterified fatty acids levels (Fig. 3C) were decreased (perhaps reflecting suppression of peripheral lipolysis by insulin) in FASKO animals, suggesting the presence of enhanced insulin sensitivity in these mice with high-fat feeding. Fasting serum triglyceride levels increased over time in both genotypes, but were 28% lower at 10 weeks in FASKO animals compared with controls (Fig. 3D). Lower triglycerides were reflected by differences in VLDL in lipoprotein analyses (not shown). Serum cholesterol levels were unaffected by genotype (not shown). Consistent with increasing adiposity in wild-type mice, serum leptin levels rose approximately8-fold over the course of the dietary intervention, while levels were lower in obesity-resistant FASKO animals (Fig. 3E). FASKO mice also resisted the HFD-induced reduction in serum adiponectin (Fig. 3F).
###end p 37
###begin p 38
###xml 602 603 600 601 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 133 137 <span type="species:ncbi:10090">Mice</span>
###xml 190 194 <span type="species:ncbi:10090">mice</span>
###xml 541 545 <span type="species:ncbi:10090">mice</span>
Serum chemistries in response to Western diet. Serum was obtained from 5 h fasted animals at 6 weeks of age on a chow diet (week 0). Mice were then started on HFD, and serum from 5 h fasted mice was obtained at weeks 4, 7, and 10. Samples were assayed for glucose (A), insulin (B), nonesterified fatty acids (C), triglycerides (D), leptin (E), and adiponectin (F). Serum lipids were analyzed on the same day of sample collection, and hormones were measured in an aliquot of snap-frozen serum samples. Graphs represent mean +/- SEM for 18-25 mice measured in five separate experiments over 24 months. * P < 0.05 compared with WT littermates.
###end p 38
###begin p 39
###xml 253 257 <span type="species:ncbi:10090">mice</span>
Fatty acid profiling by mass spectrometry within the hypothalamus of HFD-fed animals showed no genotypic differences among several fatty acids, except for a significant reduction in palmitate (C16:0), the major product of the FAS reaction, in the FASKO mice (see supplementary Table II). These findings not only further validate the FASKO model, but also show that a diet rich in palmitate (see supplementary Table I) is unable to compensate for decreased de novo synthesis at this site.
###end p 39
###begin title 40
###xml 37 41 <span type="species:ncbi:10090">mice</span>
Glucose homeostasis in HFD-fed FASKO mice
###end title 40
###begin p 41
###xml 160 167 160 167 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Fig. 4A</bold>
###xml 160 167 160 167 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig"><bold>Fig. 4A</bold></xref>
###xml 344 351 344 351 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4B</xref>
###xml 308 312 <span type="species:ncbi:10090">mice</span>
After 10 weeks of high-fat feeding, fed and 24 h-fasted serum glucose levels as well as serum insulin levels were lower in FASKO compared with control animals (Fig. 4A). There was no genotype effect on glucagon levels under these conditions (not shown). When given an acute bolus of D-glucose, HFD fed FASKO mice had lower glycemic excursions (Fig. 4B), indicating enhanced glucose tolerance.
###end p 41
###begin p 42
###xml 1238 1239 1235 1236 <italic xmlns:xlink="http://www.w3.org/1999/xlink">a</italic>
###xml 1238 1239 1235 1236 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>a</italic></sub>
###xml 1389 1390 1386 1387 <italic xmlns:xlink="http://www.w3.org/1999/xlink">d</italic>
###xml 1389 1390 1386 1387 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>d</italic></sub>
###xml 1440 1441 1435 1436 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 1456 1457 1451 1452 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 42 46 <span type="species:ncbi:10090">mice</span>
###xml 145 149 <span type="species:ncbi:10090">mice</span>
###xml 190 194 <span type="species:ncbi:10090">Mice</span>
###xml 888 892 <span type="species:ncbi:10090">mice</span>
###xml 937 941 <span type="species:ncbi:10090">Mice</span>
Glucose homeostasis in high-fat fed FASKO mice. A: Serum glucose (top panel) and insulin (bottom panel) were determined in fed and fasted (24 h) mice after 10 weeks of HFD (n = 8-11). B, C: Mice were given a bolus i.p. injection of 2 g/kg glucose, and blood glucose (B) and insulin (C) were simultaneously measured at the indicated time points (n = 10). D: Serum insulin and glucose values at the 30 min time point during the GTT were used to obtain insulin-to-glucose ratio (n = 10). E: Insulin secretion in response to 3.3 mM or 16.7 mM glucose, and 3.3 mM glucose plus 10 mM arginine in islets isolated from 10-week HFD fed WT and FASKO animals (n = 7). F: Representative pancreatic sections (x10 magnification) immunostained with anti-insulin antibodies (top panel; arrows depict insulin-positive areas) and beta cell mass (bottom panel) after 10 weeks of HFD feeding in WT and FASKO mice (n = 4). G: Insulin tolerance test (n = 8). Mice were given a bolus i.p. injection of 0.8 U/kg regular insulin, and blood glucose was subsequently measured at the indicated time points. H, I: Systemic glucose fluxes in hyperinsulinemic-euglycemic clamps following 10 weeks of HFD. Hepatic glucose output, represented as the rate of appearance (Ra) under basal and clamped (5 mU/kg/min insulin) conditions (H). Systemic insulin-dependent glucose uptake, represented as the rate of disappearance (Rd) (I) (n = 8 per group). Data are mean +/- SEM. * P < 0.05 and ** P < 0.01, compared with WT littermates.
###end p 42
###begin p 43
###xml 39 41 36 38 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib17">17</xref>
###xml 271 278 262 269 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4B</xref>
###xml 320 327 311 318 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4C</xref>
###xml 386 393 377 384 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4D</xref>
###xml 588 595 579 586 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4E</xref>
###xml 81 85 <span type="species:ncbi:10090">mice</span>
###xml 265 269 <span type="species:ncbi:10090">mice</span>
###xml 380 384 <span type="species:ncbi:10090">mice</span>
As FAS was also deleted in beta cells (17), increased glucose tolerance in FASKO mice could be caused by enhanced beta-cell function. However, two lines of evidence suggest that beta-cell function is unaffected by FAS deletion. First, lower glucose levels in FASKO mice (Fig. 4B) were matched with lower insulin levels (Fig. 4C), yielding lower insulin-to-glucose ratios in FASKO mice (Fig. 4D). Second, ex vivo insulin secretory responses of islets to glucose and arginine were nearly identical between genotypes under basal (3.3 mM glucose) and stimulated (16.7 mM glucose) conditions (Fig. 4E). These data suggest that enhanced glucose tolerance in HFD fed FASKO animals is not due to insulin hypersecretion.
###end p 43
###begin p 44
###xml 40 47 37 44 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4F</xref>
###xml 244 250 228 234 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3</xref>
###xml 290 297 271 278 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4F</xref>
###xml 355 357 336 338 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib25">25</xref>
###xml 467 474 448 455 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4G</xref>
###xml 284 288 <span type="species:ncbi:10090">mice</span>
###xml 366 370 <span type="species:ncbi:10090">mice</span>
FASKO animals had lower beta-cell mass (Fig. 4F) and a greater proportion of smaller-sized islets (19% in FASKO vs. 4% in WT had islet diameters of approximately75 mum or less), reflecting their insulin-sensitive metabolic and hormonal milieu (Fig. 3). Increased beta-cell mass in WT mice (Fig. 4F) is an expected adaptive response to insulin resistance (25). FASKO mice were more sensitive to insulin than their wild-type littermates with insulin tolerance testing (Fig. 4G).
###end p 44
###begin p 45
###xml 321 328 321 328 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4H</xref>
###xml 460 467 460 467 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4I</xref>
###xml 760 767 756 763 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Fig. 5A</bold>
###xml 760 767 756 763 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig"><bold>Fig. 5A</bold></xref>
###xml 829 836 825 832 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5A</xref>
###xml 133 137 <span type="species:ncbi:10090">mice</span>
###xml 224 228 <span type="species:ncbi:10090">mice</span>
Hyperinsulinemic-euglycemic clamp experiments suggested that the liver was the major site affected in terms of glucose metabolism in mice with hypothalamic FAS inactivation. Hepatic glucose output was lower in HFD fed FASKO mice under basal and clamped (5 mU insulin/kg/min) conditions compared with littermate controls (Fig. 4H). No differences were seen between genotypes for insulin-dependent whole-body glucose disposal with either low-dose (5 mU/kg/min) (Fig. 4I), or high-dose (20 mU/kg/min) insulin (not shown). Consistent with the clamp data, mRNA levels for peroxisome-proliferator-activated receptor gamma coactivator-1alpha, Pepck, and glucose 6-phosphatase were decreased in FASKO compared with wild-type livers after 10 weeks of high-fat feeding (Fig. 5A). Glucokinase (GK) expression was increased in FASKO livers (Fig. 5A), reflecting enhanced hepatic insulin sensitivity.
###end p 45
###begin p 46
###xml 409 410 407 408 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 486 489 484 487 <sup xmlns:xlink="http://www.w3.org/1999/xlink">473</sup>
###xml 498 499 496 497 <sup xmlns:xlink="http://www.w3.org/1999/xlink">9</sup>
###xml 536 539 534 537 <sup xmlns:xlink="http://www.w3.org/1999/xlink">256</sup>
###xml 796 797 792 793 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 195 199 <span type="species:ncbi:10090">mice</span>
###xml 388 392 <span type="species:ncbi:10090">mice</span>
Effect of hypothalamic FAS inactivation on liver and muscle insulin sensitivity. A: Expression of the indicated genes involved in glucose metabolism was measured in livers of wild-type and FASKO mice after 10 weeks of HFD by RT-PCR, and normalized to L32 ribosomal mRNA in the same sample. Each bar represents mean +/- SEM of three independent RT-PCR experiments for each gene with n = 4 mice per genotype. * P < 0.05 vs. WT. B: Immunoblot analysis in liver of total and phosphorylated 473Ser-Akt, 9Ser- glycogen synthase kinase-3beta, 256Ser-Foxo1, TRB3, and actin following the dietary intervention in response to 0.1 U/kg intraportal bolus injection of Regular insulin. C: Densitometric quantification of all liver immunoblot analyses. Data represent mean +/- SEM of five animals per group. * P < 0.05 vs. WT. D: Immunoblot analysis in gastrocnemius after 10 weeks of HFD of the above proteins following an intraportal bolus injection of 10 U/kg regular insulin. Data are representative of three independent experiments.
###end p 46
###begin p 47
###xml 261 268 261 268 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5B</xref>
###xml 270 271 270 271 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">C</xref>
###xml 317 319 317 319 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib26">26</xref>
###xml 350 357 350 357 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5B</xref>
###xml 359 360 359 360 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">C</xref>
###xml 451 458 451 458 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5B</xref>
###xml 555 562 555 562 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5D</xref>
###xml 736 740 <span type="species:ncbi:10090">mice</span>
Key mediators of insulin signaling were assayed. Increased phosphorylation of Akt at serine 473, glycogen synthase kinase-3beta at serine 9, and Foxo1 at serine 256 were seen in FASKO compared with wild-type livers in response to 0.10 U/kg intraportal insulin (Fig. 5B, C). Protein levels for TRB3, an Akt inhibitor (26), were lower in FASKO livers (Fig. 5B, C). These differences were seen in the basal state as well as with acute insulin treatment (Fig. 5B). In contrast, these effects were not seen in gastrocnemius muscles even after 10 U/kg insulin (Fig. 5D), results consistent with the clamp data suggesting that peripheral sites of metabolism such as skeletal muscle are not involved in the insulin-sensitive phenotype of FASKO mice. In addition, there was neither a dietary nor genotype-specific effect on AMPK activity in the hypothalamus (see supplementary Fig. I).
###end p 47
###begin title 48
###xml 14 18 <span type="species:ncbi:10090">mice</span>
HFD fed FASKO mice resist hepatic steatosis
###end title 48
###begin p 49
###xml 67 74 67 74 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Fig. 6A</bold>
###xml 67 74 67 74 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig6" ref-type="fig"><bold>Fig. 6A</bold></xref>
###xml 157 164 157 164 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig6" ref-type="fig">Fig. 6B</xref>
###xml 256 263 256 263 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig6" ref-type="fig">Fig. 6C</xref>
###xml 265 266 265 266 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig6" ref-type="fig">D</xref>
###xml 308 315 308 315 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig6" ref-type="fig">Fig. 6E</xref>
###xml 405 412 405 412 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5D</xref>
###xml 522 524 522 524 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib27">27</xref>
###xml 558 565 558 565 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig6" ref-type="fig">Fig. 6F</xref>
###xml 629 631 629 631 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib28">28</xref>
###xml 719 726 719 726 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig6" ref-type="fig">Fig. 6F</xref>
###xml 825 827 821 823 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib29">29</xref>
###xml 672 676 <span type="species:ncbi:10090">mice</span>
FASKO livers weighed 27% less than controls with high-fat feeding (Fig. 6A). Decreased Oil Red O staining (reflecting decreased abundance of neutral lipids; Fig. 6B, bottom panel) in FASKO livers mirrored quantitative assessments of hepatic lipid content (Fig. 6C, D). Triglyceride content in gastrocnemius (Fig. 6E) was unaffected, consistent with the lack of effect on insulin signaling in this tissue (Fig. 5D). Expression of sterol-regulatory element binding protein-1c, an important regulator of hepatic lipogenesis (27), was decreased in FASKO livers (Fig. 6F). Gene expression of FAT/CD36, normally not abundant in liver (28), was higher in the livers of wild-type mice with increased triglyceride accumulation (Fig. 6F). Hepatic Ppargamma expression, implicated in the development and maintenance of liver steatosis (29), was not affected by genotype under these conditions (not shown). Thus, the metabolic milieu in the FASKO animals favorably alters hepatic lipid metabolism to protect against diet-induced fatty liver.
###end p 49
###begin p 50
###xml 844 845 842 843 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 6 10 <span type="species:ncbi:10090">mice</span>
###xml 100 104 <span type="species:ncbi:10090">mice</span>
###xml 561 565 <span type="species:ncbi:10090">mice</span>
###xml 823 827 <span type="species:ncbi:10090">mice</span>
FASKO mice are resistant to HFD-induced fatty liver. A: Average weights of livers from WT and FASKO mice after 10 weeks of high-fat feeding (n = 18). B: Liver sections stained with H and E, and Oil Red O (ORO) at x10 magnification. The prominent vacuolation seen in HFD-fed WT livers (arrows, top panel) stained positive for ORO (bottom panel). Sections are representative of 6-8 animals per group. C-E: Hepatic triglyceride (C) and cholesterol (D) content, and triglyceride content per unit mass in gastrocnemius (E) isolated from 10-week HFD-fed WT and FASKO mice (n = 7). F: Expression of hepatic sterol-regulatory element binding protein-1c and CD36 mRNA by RT-PCR normalized to L32 ribosomal mRNA after 10 weeks of HFD. Each bar represents mean +/- SEM of three independent RT-PCR experiments for each gene with n = 4 mice per genotype. * P < 0.05 vs. WT.
###end p 50
###begin title 51
###xml 56 60 <span type="species:ncbi:10090">mice</span>
Less oxidative stress and inflammation in HFD fed FASKO mice
###end title 51
###begin p 52
###xml 250 252 250 252 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib30">30</xref>
###xml 323 325 323 325 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2t</sub>
###xml 380 387 380 387 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Fig. 7A</bold>
###xml 380 387 380 387 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig7" ref-type="fig"><bold>Fig. 7A</bold></xref>
###xml 521 528 521 528 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig7" ref-type="fig">Fig. 7B</xref>
###xml 823 830 819 826 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig7" ref-type="fig">Fig. 7C</xref>
###xml 832 833 828 829 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig7" ref-type="fig">D</xref>
###xml 374 378 <span type="species:ncbi:10090">mice</span>
###xml 531 535 <span type="species:ncbi:10090">Mice</span>
Nutrient excess, insulin resistance, hepatic steatosis, and other characteristics of the obese state contribute to the increased production of reactive oxygen species, which have been implicated in chronic inflammation and complications of diabetes (30). Urinary levels of a biomarker for oxidative stress, 15-isoprostane F2t, were lower in FASKO as compared with wild-type mice (Fig. 7A). Fewer mononuclear inflammatory cells, predominantly macrophages, were detected in FASKO as compared with wild-type adipose tissue (Fig. 7B). Mice were also challenged with a nonlethal dose of lipopolysaccharide, a potent endotoxin. As expected, endotoxinemia markedly increased cytokine levels in both genotypes. However, the peak levels for TNFalpha and IL-6 were substantially attenuated in FASKO as compared with wild-type serum (Fig. 7C, D).
###end p 52
###begin p 53
###xml 100 102 100 102 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2t</sub>
###xml 1129 1130 1119 1120 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 580 584 <span type="species:ncbi:10090">mice</span>
###xml 678 682 <span type="species:ncbi:10090">mice</span>
###xml 721 725 <span type="species:ncbi:10090">mice</span>
Effect of 10 weeks of HFD on oxidative stress and systemic inflammation. A: Urinary 15-isoprostane F2t normalized to creatinine levels (n = 8-9 per genotype). Data represent mean values from two independent experiments each repeated twice. B: Representative perigonadal white adipose tissue sections (x40 magnification) immunostained with antibodies against the macrophage-specific antigen F4/80 (thick arrows), and counterstained with hematoxylin, demonstrating other mononuclear cells (thin arrows). F4/80-positive cells were more abundant and aggregated in the obese wild-type mice (top panel), whereas these cells were sparse and isolated in the leaner FASKO (bottom panel) mice. Sections are representative of n = 4 mice per genotype. C, D: Serum tumor necrosis factor alpha (TNFalpha) and interleukin-6 (IL-6) concentrations. After 10 weeks of HFD, animals were injected intraperitoneally with 7 mg/kg lipopolysaccharide, and serum TNFalpha (C) and IL-6 (D) concentrations were then measured at the indicated time points (n = 7 per group). A, C, D: Data represent mean +/- SEM of two separate experiments over 18 months. * P < 0.05 vs. WT.
###end p 53
###begin title 54
Pair-feeding studies
###end title 54
###begin p 55
###xml 480 487 480 487 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Fig. 8A</bold>
###xml 480 487 480 487 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig8" ref-type="fig"><bold>Fig. 8A</bold></xref>
###xml 487 488 487 488 <bold xmlns:xlink="http://www.w3.org/1999/xlink">&#8211;</bold>
###xml 488 489 488 489 <bold xmlns:xlink="http://www.w3.org/1999/xlink">C</bold>
###xml 488 489 488 489 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig8" ref-type="fig"><bold>C</bold></xref>
###xml 536 543 536 543 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig8" ref-type="fig">Fig. 8D</xref>
###xml 710 717 710 717 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig8" ref-type="fig">Fig. 8E</xref>
###xml 782 785 782 785 <sup xmlns:xlink="http://www.w3.org/1999/xlink">473</sup>
###xml 860 867 860 867 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig8" ref-type="fig">Fig. 8F</xref>
###xml 1033 1034 1029 1030 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 1357 1364 1349 1356 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig8" ref-type="fig">Fig. 8G</xref>
###xml 221 225 <span type="species:ncbi:10090">mice</span>
###xml 618 622 <span type="species:ncbi:10090">mice</span>
###xml 750 754 <span type="species:ncbi:10090">mice</span>
###xml 929 933 <span type="species:ncbi:10090">mice</span>
###xml 1351 1355 <span type="species:ncbi:10090">mice</span>
###xml 1429 1433 <span type="species:ncbi:10090">mice</span>
To determine whether changes in oxygen consumption, hepatic insulin signaling, and systemic inflammation are a consequence of the targeted disruption of hypothalamic FAS, we food restricted a separate cohort of wild-type mice by pair-feeding them to FASKO animals for 15 days following 10 wks of high-fat feeding. This intervention resulted in considerable weight loss leading to nearly identical body weight and adiposity in the pair-fed wild-type and freely- fed FASKO animals (Fig. 8A-C). The percentage of lean mass was unaffected (Fig. 8D). Remarkably, despite this reduction in adiposity, the pair-fed wild-type mice continued to show similar oxygen consumption as the ad libitum fed wild-type controls (Fig. 8E). The leaner pair-fed wild-type mice failed to increase hepatic 473Ser-Akt phosphorylation above that of obese freely fed wild-type controls (Fig. 8F), despite having similar fasting insulin levels as the FASKO mice (2.3 +/- 0.6 ng/ml in ad libitum HFD-fed FASKO vs. 3.1 +/- 0.8 ng/ml in pair-fed wild-type, n = 6, P = NS). This finding further confirms the increased hepatic insulin sensitivity in FASKO animals. Pair-feeding wild-type with FASKO animals also did not lower their peak serum TNFalpha concentration (at 1 h) in response to lipopolysaccharide injection, which remained comparable to freely fed obese wild-type control mice (Fig. 8G). Because, by design, adiposity in FASKO and pair-fed wild-type mice was the same, the higher oxygen consumption, increased Akt phosphorylation, and lower serum TNFalpha levels in response to endotoxin in the FASKO animals suggest that these effects are due to hypothalamic FAS inactivation, rather than a consequence of adiposity.
###end p 55
###begin p 56
###xml 419 420 417 418 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 483 486 481 484 <sup xmlns:xlink="http://www.w3.org/1999/xlink">473</sup>
###xml 758 759 754 755 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 780 781 776 777 <sup xmlns:xlink="http://www.w3.org/1999/xlink">#</sup>
###xml 781 782 777 778 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 1016 1017 1006 1007 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 1038 1039 1028 1029 <sup xmlns:xlink="http://www.w3.org/1999/xlink">#</sup>
###xml 1039 1040 1029 1030 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 45 49 <span type="species:ncbi:10090">mice</span>
###xml 82 86 <span type="species:ncbi:10090">mice</span>
###xml 905 909 <span type="species:ncbi:10090">mice</span>
Pair-feeding studies in HFD fed WT and FASKO mice. A-E: Effect of pair-feeding WT mice to ad libitum fed FASKO animals on body weight gain (A), percent change in body weight compared with corresponding ad libitum fed controls (B), adiposity (C), percentage of lean mass (D), and oxygen consumption (by indirect calorimetry integrated over a 24 h period) (E). Results represent mean +/- SEM of 7-10 animals per group. * P < 0.05 compared with WT control (Ctrl). F: Immunoblotting for 473Ser-phosphorylated and total Akt in the liver after pair-feeding in response to an intraportal bolus injection of 0.1 U/kg regular insulin (top panel), and corresponding densitometric quantification (bottom panel). Data represent mean +/- SEM of four animals per group. * P < 0.05 vs. WT-Ctrl. #P < 0.05 vs. WT-pair-fed. G: Serum TNFalpha concentration at the indicated time points in control and pair-fed WT and FASKO mice in response to 7 mg/kg lipopolysaccharide injection. Results are mean +/- SEM of 5-6 animals per group. * P < 0.05 vs. WT-Ctrl. #P < 0.05 vs. WT-PF. H: An integrative model for the regulatory role of brain FAS in energy homeostasis. Hypothalamic FAS deficiency impacts multiple organ systems culminating in resistance to diet-induced obesity (DIO) and increased insulin sensitivity.
###end p 56
###begin title 57
DISCUSSION
###end title 57
###begin p 58
###xml 394 396 394 396 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib31">31</xref>
###xml 473 475 473 475 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib32">32</xref>
###xml 530 532 530 532 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib33">33</xref>
###xml 388 392 <span type="species:ncbi:10090">mice</span>
###xml 440 444 <span type="species:ncbi:10090">mice</span>
###xml 489 493 <span type="species:ncbi:10090">mice</span>
###xml 873 877 <span type="species:ncbi:10090">mice</span>
Simply decreasing adiposity may not be sufficient for treating obesity-related disorders such as the metabolic syndrome and type 2 diabetes. There are examples of disruption of the expected inverse relationship between adiposity and aberrant metabolism. Despite decreased adiposity, inactivation of stearoyl-CoA desaturase-1 promotes the development of diabetes in leptin-deficient ob/ob mice (31). Conversely, despite increased adiposity, mice with inactivation of TLR-4 (32), as well as mice with overexpression of adiponectin (33), have enhanced insulin sensitivity. Novel therapies most likely to provide benefit will not only decrease adiposity but also ameliorate pathophysiologic conditions such as insulin resistance, fatty liver, and systemic inflammation. Here we demonstrate that central nervous system inhibition of de novo lipogenesis mediated by FAS protects mice from HFD-induced diabetes and results in enhanced hepatic insulin signaling, less fatty liver, decreased circulating triglycerides and free fatty acids, an improved adipokine profile, and evidence of decreased oxidative stress as well as systemic inflammation.
###end p 58
###begin p 59
###xml 162 164 162 164 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib17">17</xref>
###xml 562 564 558 560 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib20">20</xref>
###xml 791 793 787 789 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib17">17</xref>
###xml 1116 1123 1112 1119 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig8" ref-type="fig">Fig. 8E</xref>
###xml 38 42 <span type="species:ncbi:10090">mice</span>
###xml 340 344 <span type="species:ncbi:10090">mice</span>
###xml 765 769 <span type="species:ncbi:10090">mice</span>
Our initial characterization of these mice on standard chow demonstrated decreased adiposity due to a combination of hypophagia and increased locomotor activity (17). The current results extend this work by showing that the decreased food intake and increased activity phenotype is preserved in the setting of high-fat feeding and protects mice from obesity. These findings, while logical, were not necessarily predictable. The product of the FAS reaction, mostly palmitate, appears to serve a signaling function that includes activation of Pparalpha signaling (20). Due to the fact that HFDs are enriched in palmitate (see supplementary Table I), it was possible that the provision of large amounts of this molecule could reverse the behavioral phenotype of these mice. This did not occur (17), indicating that either dietary palmitate cannot substitute for the product of the FAS reaction in brain or FAS is compartmentalized in the central nervous system to sites critical for energy homeostasis. Our pair-feeding studies support a potentially direct role for hypothalamic FAS in the regulation of bioenergetics (Fig. 8E).
###end p 59
###begin p 60
###xml 257 259 251 253 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib34">34</xref>
###xml 383 385 377 379 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib17">17</xref>
###xml 400 406 394 400 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4</xref>
###xml 275 279 <span type="species:ncbi:10090">mice</span>
###xml 354 358 <span type="species:ncbi:10090">mice</span>
The current data also show that the absence of FAS expression in pancreatic beta cells does not affect beta-cell function even under conditions of nutrient excess. In reductionist systems, de novo lipogenesis in islets may be important for normal function (34) but in intact mice, this process does not impact insulin secretion from islets isolated from mice following low-fat chow (17) or high-fat (Fig. 4) feeding.
###end p 60
###begin p 61
###xml 223 225 220 222 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib35">35</xref>
###xml 331 335 <span type="species:ncbi:10090">mice</span>
###xml 385 389 <span type="species:ncbi:10090">mice</span>
Limitations to this work include the fact that these animals are in a mixed (BL/6 and 129) background and utilize the RIP-driven ectopic expression of the Cre recombinase, which has been shown to affect beta-cell function (35). While genetic admixture and Cre could have confounding effects, controls were littermates of the FASKO mice and included Cre only in addition to floxed only mice. We also failed to observe any beta-cell phenotype.
###end p 61
###begin p 62
###xml 116 123 116 123 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4H</xref>
###xml 175 182 175 182 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4I</xref>
###xml 430 436 430 436 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5</xref>
###xml 558 564 558 564 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig6" ref-type="fig">Fig. 6</xref>
###xml 744 751 744 751 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig6" ref-type="fig">Fig. 6F</xref>
###xml 993 1000 993 1000 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2G</xref>
###xml 1214 1216 1214 1216 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib36">36</xref>
###xml 1376 1383 1376 1383 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig6" ref-type="fig">Fig. 6F</xref>
###xml 1472 1474 1472 1474 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib29">29</xref>
###xml 1519 1526 1519 1526 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2H</xref>
###xml 1643 1645 1643 1645 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib37">37</xref>
###xml 68 72 <span type="species:ncbi:10090">mice</span>
###xml 262 266 <span type="species:ncbi:10090">mice</span>
###xml 424 428 <span type="species:ncbi:10090">mice</span>
###xml 473 477 <span type="species:ncbi:10090">mice</span>
###xml 738 742 <span type="species:ncbi:10090">mice</span>
###xml 1176 1181 <span type="species:ncbi:10090">mouse</span>
###xml 1483 1487 <span type="species:ncbi:10090">mice</span>
Beneficial effects at the liver were striking in high-fat fed FASKO mice. Hepatic glucose production was decreased (Fig. 4H) without an effect on peripheral glucose disposal (Fig. 4I), suggesting that much of the enhanced glucose tolerance in high-fat fed FASKO mice was due to effects at the liver. Consistent with this observation, insulin signaling was increased in liver but not muscle of FASKO as compared with control mice (Fig. 5). In FASKO as compared with control mice, the lipid content of liver but not muscle was decreased with high-fat feeding (Fig. 6). Expression of sterol-regulatory element binding protein-1c, an insulin responsive transcription factor important for lipogenesis, was substantially decreased in the FASKO mice (Fig. 6F), which likely contributes to their protection from fatty liver because their tissues were notable for the absence of up-regulated expression of genes involved in fat oxidation, uncoupled oxidative phosphorylation, or futile energy cycling (Fig. 2G). Consistent with our sterol-regulatory element binding protein-1c findings in liver, hepatic sterol-regulatory element binding protein expression is known to be increased in mouse models of obesity and diabetes (36). Additional mechanisms may also be involved in the protection from hepatic steatosis. CD36 expression was decreased in FASKO as compared with control livers (Fig. 6F), consistent with previous reports showing CD36 up-regulation in HFD-induced steatosis (29). FASKO mice are more active than controls (Fig. 2H), consistent with studies implicating increased physical activity in the protection against fatty liver in rodents (37).
###end p 62
###begin p 63
###xml 104 106 104 106 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib17">17</xref>
###xml 270 272 270 272 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib38">38</xref>
###xml 307 309 307 309 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib39">39</xref>
###xml 425 427 421 423 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib17">17</xref>
###xml 429 431 425 427 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib20">20</xref>
###xml 566 568 558 560 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib17">17</xref>
###xml 98 102 <span type="species:ncbi:10090">mice</span>
###xml 440 444 <span type="species:ncbi:10090">mice</span>
Observations from the present study with high-fat feeding and our previous data in chow-fed FASKO mice (17) collectively support the notion of FAS functioning as a nutritional sensor within the hypothalamus. Inhibition of hypothalamic carnitine palmitoyl transferase-1 (38) and accumulation of malonyl-CoA (39) independently reduce food intake. Products of the FAS reaction serve as endogenous ligands to activate PPARalpha (17, 20). FASKO mice demonstrate reduced expression of carnitine palmitoyl transferase-1 and malonyl-CoA decarboxylase, targets of PPARalpha (17). Thus, manipulations of hypothalamic fatty acid oxidation (via inhibition of carnitine palmitoyl transferase-1) and synthesis (via accumulation of malonyl-CoA) that alter feeding behavior can be orchestrated through FAS.
###end p 63
###begin p 64
###xml 257 259 257 259 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib24">24</xref>
###xml 261 263 261 263 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib40">40</xref>
###xml 265 267 265 267 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib41">41</xref>
###xml 428 430 428 430 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib24">24</xref>
###xml 545 547 545 547 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib40">40</xref>
###xml 659 661 659 661 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib41">41</xref>
###xml 786 793 786 793 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4H</xref>
###xml 869 876 869 876 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5B</xref>
###xml 878 879 878 879 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">C</xref>
###xml 955 962 955 962 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig8" ref-type="fig">Fig. 8F</xref>
###xml 539 543 <span type="species:ncbi:10118|species:ncbi:10116">rats</span>
###xml 616 620 <span type="species:ncbi:10118|species:ncbi:10116">rats</span>
Inactivation of hypothalamic FAS also affects glucose metabolism, providing another example of how FAS might serve as a nutritional sensor and contributing to a growing body of evidence identifying the brain-liver axis as a mediator of glucose homeostasis (24, 40, 41). Disrupting central nervous system liver neural signaling lowers blood glucose and blood pressure in the setting of glucocorticoid-induced insulin resistance (24). Central inhibition of lipid oxidation in the hypothalamus decreases hepatic glucose production in overfed rats (40). Central administration of lactate decreases glucose production in rats with diet-induced insulin resistance (41). Now we show that inactivation of lipogenesis in the hypothalamus (see supplementary Table II) reduces glucose production (Fig. 4H) and enhances hepatic insulin signaling in the setting of nutrient excess (Fig. 5B, C), independent of AMPK activation (see supplementary Fig. I) and adiposity (Fig. 8F). As glucose production by the liver is the main endogenous fuel source, hypothalamic FAS appears to regulate exogenous (via food intake) and endogenous (via glucose production) energy availability.
###end p 64
###begin p 65
###xml 60 62 60 62 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib42">42</xref>
###xml 100 102 100 102 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib43">43</xref>
###xml 104 106 104 106 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib44">44</xref>
###xml 221 223 221 223 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib30">30</xref>
###xml 321 322 321 322 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib6">6</xref>
###xml 322 322 322 322 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib7"/>
###xml 322 322 322 322 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib8"/>
###xml 322 322 322 322 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib9"/>
###xml 322 322 322 322 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib10"/>
###xml 322 322 322 322 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib11"/>
###xml 322 322 322 322 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib12"/>
###xml 322 322 322 322 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib13"/>
###xml 323 325 323 325 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib14">14</xref>
###xml 561 563 558 560 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib11">11</xref>
###xml 636 638 633 635 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib16">16</xref>
###xml 762 764 759 761 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib45">45</xref>
###xml 817 824 814 821 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig7" ref-type="fig">Fig. 7A</xref>
###xml 919 926 912 919 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig7" ref-type="fig">Fig. 7C</xref>
###xml 928 929 921 922 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig7" ref-type="fig">D</xref>
###xml 997 999 990 992 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib46">46</xref>
###xml 1001 1003 994 996 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib47">47</xref>
###xml 1093 1095 1086 1088 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib23">23</xref>
###xml 1202 1204 1195 1197 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib48">48</xref>
###xml 1206 1208 1199 1201 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib49">49</xref>
###xml 1307 1314 1300 1307 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig7" ref-type="fig">Fig. 7B</xref>
###xml 786 790 <span type="species:ncbi:10090">mice</span>
###xml 1301 1305 <span type="species:ncbi:10090">mice</span>
Systemic oxidative stress correlates with fat accumulation (42) and may promote insulin resistance (43, 44). Increasing oxidative metabolism increases production of reactive oxygen species, which may induce inflammation (30). Thus, while increasing fat oxidation might be considered beneficial by decreasing body weight (6-14), it may increase reactive oxygen species, and, depending on the tissue in which such species are generated, this effect could impair physiology. Global stearoyl-CoA desaturase-1 deficiency, which increases the rate of beta-oxidation (11), increases proinflammatory cytokines and predisposes to acute colitis (16). Accelerating metabolism specifically in the vasculature increases the chronic inflammatory condition of atherosclerosis (45). In contrast, FASKO mice have less oxidant stress (Fig. 7A) and less systemic inflammation as manifested by decreased serum levels of TNFalpha and IL-6 (Fig. 7C, D), inflammatory markers elevated in insulin resistance and obesity (46, 47). At least some of this effect is mediated by macrophage accumulation in adipose tissue (23), and insulin resistance is ameliorated by inhibiting macrophage recruitment in animal models of obesity (48, 49). Consistent with these findings, macrophages were less apparent in adipose tissue of FASKO mice (Fig. 7B, bottom).
###end p 65
###begin p 66
###xml 230 236 230 236 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig8" ref-type="fig">Fig. 8</xref>
###xml 324 331 324 331 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig8" ref-type="fig">Fig. 8C</xref>
###xml 511 518 507 514 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig8" ref-type="fig">Fig. 8G</xref>
###xml 735 737 727 729 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib50">50</xref>
###xml 41 45 <span type="species:ncbi:10090">mice</span>
###xml 279 283 <span type="species:ncbi:10090">mice</span>
###xml 364 368 <span type="species:ncbi:10090">mice</span>
###xml 683 687 <span type="species:ncbi:10118|species:ncbi:10116">rats</span>
###xml 785 789 <span type="species:ncbi:10090">mice</span>
Although decreased inflammation in FASKO mice could reflect decreased adiposity, this effect appears to be due to a specific consequence of central FAS deficiency rather than body-fat content as suggested by pair-feeding studies (Fig. 8). Despite reducing adiposity of wild-type mice to the same level as the FASKO animals (Fig. 8C), the leaner pair-fed wild-type mice continued to manifest similar peak serum TNFalpha concentrations as the obese ad libitum HFD fed wild-type controls in response to endotoxin (Fig. 8G). These studies lend support to the notion that the brain can affect inflammation. Electrical stimulation of the vagus nerve in vivo during lethal endotoxinemia in rats attenuates TNFalpha levels and prevents shock (50). Perturbation of de novo lipogenesis in FASKO mice, which alters systemic energy balance, also appears to directly affect systemic inflammation.
###end p 66
###begin p 67
###xml 224 231 224 231 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig8" ref-type="fig">Fig. 8H</xref>
In summary, our data suggest a critical role for hypothalamic FAS in the orchestration of bioenergetics, hepatic insulin signaling, and systemic inflammation resulting in obesity-resistance and enhanced insulin sensitivity (Fig. 8H). Medicinal chemists frequently pursue potential drug targets with a goal of excluding compounds from the central nervous system in hopes of diminishing behavioral side effects. The current data suggest that a strategy of targeting FAS at specific sites in the brain could coordinately improve multiple features of obesity-related disease.
###end p 67
###begin title 68
Supplementary Material
###end title 68
###begin title 69
Supplemental Data
###end title 69
###begin title 70
Abbreviations
###end title 70
###begin p 71
HFD, high-fat diet
###end p 71
###begin p 72
IL-6, interleukin-6
###end p 72
###begin p 73
FASKO, fatty acid synthase knockout
###end p 73
###begin p 74
Ppar, peroxisome-proliferator-activated receptor
###end p 74
###begin p 75
TNFalpha, tumor necrosis factor alpha
###end p 75
###begin p 76
We thank Dr. Barbara Mickelson at Harlan Teklad for her assistance with obtaining fatty acid composition of the high-fat diet. We are indebted to Dr. John Turk for his expert advice regarding lipid mass spectrometric analyses.
###end p 76
###begin p 77
###xml 31 60 31 60 <grant-sponsor xmlns:xlink="http://www.w3.org/1999/xlink">American Diabetes Association</grant-sponsor>
###xml 152 181 152 181 <grant-sponsor xmlns:xlink="http://www.w3.org/1999/xlink">National Institutes of Health</grant-sponsor>
###xml 189 197 189 197 <grant-num xmlns:xlink="http://www.w3.org/1999/xlink">DK076729</grant-num>
###xml 202 214 202 214 <grant-num xmlns:xlink="http://www.w3.org/1999/xlink">P50 HL083762</grant-num>
###xml 224 256 224 256 <grant-sponsor xmlns:xlink="http://www.w3.org/1999/xlink">Clinical Nutrition Research Unit</grant-sponsor>
###xml 271 308 271 308 <grant-sponsor xmlns:xlink="http://www.w3.org/1999/xlink">Diabetes Research and Training Center</grant-sponsor>
This work was supported by the American Diabetes Association (Junior Faculty Award 1-07-JF-12 to MVC and a Mentor-Based Postdoctoral Fellowship Award), National Institutes of Health grants DK076729 and P50 HL083762, and the Clinical Nutrition Research Unit (DK56341) and Diabetes Research and Training Center (DK20579).
###end p 77
###begin p 78
###xml 0 2 0 2 <sup xmlns:xlink="http://www.w3.org/1999/xlink">s&#8414;</sup>
sâƒžThe online version of this article (available at ) contains supplementary data in the form of two tables and one figure.
###end p 78

